Agios Pharmaceuticals (AGIO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $22.1 million.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments rose 42474.42% to $22.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.1 million, marking a year-over-year increase of 42474.42%. This contributed to the annual value of $22.1 million for FY2025, which is 42474.42% up from last year.
- Latest data reveals that Agios Pharmaceuticals reported Other Gross PP&E Adjustments of $22.1 million as of Q4 2025, which was up 42474.42% from -$33.6 million recorded in Q3 2025.
- In the past 5 years, Agios Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $22.1 million in Q4 2025 and a low of -$82.2 million during Q1 2021
- In the last 5 years, Agios Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$50.2 million in 2024 and averaged -$45.7 million.
- In the last 5 years, Agios Pharmaceuticals' Other Gross PP&E Adjustments surged by 1005.69% in 2021 and then surged by 42474.42% in 2025.
- Quarter analysis of 5 years shows Agios Pharmaceuticals' Other Gross PP&E Adjustments stood at -$28.4 million in 2021, then surged by 35.63% to -$18.3 million in 2022, then surged by 57.66% to -$7.8 million in 2023, then soared by 154.22% to $4.2 million in 2024, then soared by 424.74% to $22.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at $22.1 million for Q4 2025, versus -$33.6 million for Q3 2025 and -$36.8 million for Q2 2025.